In single-center study, GLP-1 use in people with type 1 diabetes was associated with lower hospitalization rates.

Sedentary behaviour is associated with an increased risk of cardiovascular disease and all-cause mortality in people with ...

A major clinical trial has found that real-time continuous glucose monitoring (CGM) significantly improves blood glucose ...

Abbott winning another round against Sinocare and Menarini, and the Mannheim Local Division granting Nokia an interim ...

New glucose sensors and a partnership with Abbott are expected to drive sales growth at MiniMed, BTIG analyst Marie Thibault ...

Buy the dip on Abbott (ABT): diversified healthcare growth, Exact Sciences boost, strong dividend, and discounted ...

More and more patients are developing type 2 diabetes while still young. The diagnosis may lead to a life of disease.

Abbott Laboratories ( ABT +1.49%) more or less met analyst estimates in its first quarter, the results of which were ...

Abbott, a leading global healthcare company, has reported strong first-quarter (Q1) 2026 earnings and achieved several ...

CEO Robert B. Ford remains optimistic about the company's opportunity in the continuous glucose monitor (CGM) market.

Abbott cut its annual profit forecast on Thursday due to an impact from its $23 billion acquisition of cancer test maker ...